[A Case of Successful Curative Treatment Following Chemotherapy for Gastric Cancer with Sister Mary Joseph's Nodule]

Sohsuke Hara1, Hiroki Ureshino, Yasushi Yoshida

  • 1Dept. of Surgery, Fukuoka Tokushukai Hospital.

A woman in her 50s presented to our department of plastic surgery with a complaint of a nodule in the umbilical region. CT revealed an umbilical tumor and thickening of the anterior wall of the stomach, raising suspicion of gastric cancer with umbilical metastasis. She was referred to surgery. Upper endoscopy identified advanced gastric cancer(type 2)in the greater curvature of the gastric body. PET-CT showed abnormal uptake in the greater curvature of the gastric body, umbilical region, right ovary, and lymph nodes. She was diagnosed with gastric cancer(T4aN3aM1, cStage ⅣB)and underwent chemotherapy. A CT scan after the fourth course showed significant tumor shrinkage, making identification difficult. After 9 months of chemotherapy, upper endoscopy showed marked tumor shrinkage, and CT and PET-CT scans showed that the primary and metastatic lesions were indistinguishable. Exploratory laparoscopy and umbilical biopsy revealed no gross dissemination, and histologically, no tumor cells were found in the umbilical area or ascites. Conversion surgery was deemed appropriate and performed, including distal gastrectomy with bilateral salpingo-oophorectomy. No metastases were found in the lymph nodes or adnexa, and she was diagnosed with ypStage ⅠB(T2N0M0). Adjuvant chemotherapy was administered, and she remains recurrence-free 14 months post-surgery.

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
194
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
147
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60